Lithium and Quetiapine in Depression
Anxiety and Depression are, more often than not, found to go hand in hand. Most of the time, alleviating symptoms for one, helps in managing the other.
We are carrying out a study on people who have found that their antidepressants aren’t really helping their depressive symptoms.
If the study is found to be right for you by our clinicians and researchers, you would be prescribed either Lithium or Quetiapine, two of the most widely used and prescribed treatments for people who have not responded to antidepressants.
The study is taking place across sites with hubs in London, Oxfordshire and Newcastle.
To be suitable for the study, you must:
The Institute of Psychiatry, Psychology and Neuroscience is running the study with sponsorship provided by King’s College London and the South London and Maudsley NHS Foundation Trust and funding provided by the National Institute for Health Research.
If you’re interested in taking part, or just want more information, please contact the study team on: LQDstudy@kcl.ac.uk or call us on 07902774464. All information remains confidential.
You can also visit our website: https://www.kcl.ac.uk/ioppn/depts/pm/research/CfAD/LQDStudy.aspx
Or follow us on Twitter: @lqd_study
Cognitive-behaviour therapy and losartan for panic attacks
Panic attacks? Oxford University offers cognitive-behavioural therapy session Do you keep experiencing very strong physical symptoms like heart racing, breathlessness, dizziness or nausea? Are these symptoms related to strong fear of having a heart attack, fainting, suffocating, or going mad? Has your GP suggested that these symptoms might be of psychological origin?
You could have panic disorder. Cognitive-behavioural therapy (CBT) is an effective way of regaining control, independence and life quality. The Department of Psychiatry at the University of Oxford tests the effects of a new brief combination treatment as part of a research project, to identify the underlying brain mechanisms of successful therapy. This study may involve a brain scan, but please note that you will be given the choice to opt out of this part of the study. If you are interested in participating, and for more information, please contact us directly, or have a look at our website. Time and travel expenses are reimbursed.
Contact Andrea Reinecke email@example.com or visit http://www.oxited.co.uk/ongoing-treatment-study.html for more details.
Genetic Links to Anxiety & Depression
Exciting new opportunity to engage in anxiety/depression research
Depression and anxiety are common but complex disorders whose research needs very large sample sizes. The Genetic Links to Anxiety and Depression (GLAD) study launches this September and aims to recruit >40,000 individuals. Anyone age 16 years or older who has experienced anxiety or depression during their lives can join this recontactable database to facilitate future research. Participants will also join a national Mental Health BioResource and contribute to the largest ever single study of anxiety and depression.
How can I take part?
All enrollment takes place online at our website, www.gladstudy.org.uk. An online animation explains the consent process with more detailed information in text format. Once you have provided consent and completed an online questionnaire you will be sent a saliva DNA sample kit to enable genetic studies.
We really hope you will join us in this important endeavour.